Back
53
Day Range
$22.04
$22.67
52-Week Range
$16.52
$25.15
Volume
543,850
50D / 200D Avg
$21.55
/
$20.16
Prev Close
$21.92
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 5.4 | 0.2 |
| P/B | 1.2 | 3.0 |
| ROE % | 29.1 | 3.6 |
| Net Margin % | 63.8 | 3.8 |
| Rev Growth 5Y % | 2.1 | 9.9 |
| D/E | 0.2 | 0.2 |
Analyst Price Target
Hold
$32.50
+43.9%
Low: $17.00
High: $46.00
Forward P/E
11.80
Forward EPS
$1.91
EPS Growth (est.)
+0.0%
Est. Revenue
439.36M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$1.84
$1.68 – $1.97
|
654.34M | 1 |
| FY2029 |
$2.72
$2.48 – $2.91
|
607.94M | 1 |
| FY2028 |
$2.00
$1.62 – $2.38
|
543.05M | 2 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-25 | $0.55 | $1.94 | +252.1% |
| 2025-11-05 | $0.46 | $1.08 | +134.8% |
| 2025-08-06 | $0.57 | $0.77 | +35.1% |
| 2025-05-07 | $0.29 | $0.25 | -13.8% |
| 2025-02-26 | $0.34 | $0.57 | +67.6% |
| 2024-11-06 | $0.27 | $0.02 | -92.6% |
| 2024-07-31 | $0.24 | $0.68 | +183.3% |
| 2024-05-08 | $0.17 | $0.46 | +170.6% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Sep 08, 2015 | Sep 30, 2015 | $0.25 | 7.39% |
| Jun 10, 2015 | Jun 30, 2015 | $0.25 | 5.63% |
| Mar 10, 2015 | Mar 31, 2015 | $0.25 | 3.92% |
| Nov 21, 2014 | Dec 23, 2014 | $0.25 | 3.74% |
| Aug 26, 2014 | Sep 18, 2014 | $0.25 | 1.15% |
Key Takeaways
Revenue grew 2.06% annually over 5 years — modest growth
Earnings grew 1059.22% over the past year
ROE of 29.09% indicates high profitability
Net margin of 63.78% shows strong profitability
Debt/Equity of 0.23 — conservative balance sheet
Generating 195.80M in free cash flow
Growth
Revenue Growth (5Y)
2.06%
Revenue (1Y)18.52%
Earnings (1Y)1059.22%
FCF Growth (3Y)17.99%
Quality
Return on Equity
29.09%
ROIC8.52%
Net Margin63.78%
Op. Margin38.52%
Safety
Debt / Equity
0.23
Current Ratio14.64
Interest Coverage9.81
Valuation
P/E Ratio
5.36
Forward P/E11.80
P/B Ratio1.24
EV/EBITDA7.15
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 18.52% | Revenue Growth (3Y) | 17.02% |
| Earnings Growth (1Y) | 1059.22% | Earnings Growth (3Y) | 22.83% |
| Revenue Growth (5Y) | 2.06% | Earnings Growth (5Y) | 0.50% |
| Profitability | |||
| Revenue (TTM) | 425.13M | Net Income (TTM) | 271.17M |
| ROE | 29.09% | ROA | 16.58% |
| Gross Margin | 72.33% | Operating Margin | 38.52% |
| Net Margin | 63.78% | Free Cash Flow (TTM) | 195.80M |
| ROIC | 8.52% | FCF Growth (3Y) | 17.99% |
| Safety | |||
| Debt / Equity | 0.23 | Current Ratio | 14.64 |
| Interest Coverage | 9.81 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 5.36 | Forward P/E | 11.80 |
| P/B Ratio | 1.24 | P/S Ratio | 3.42 |
| PEG Ratio | 0.01 | Forward PEG | N/A |
| EV/EBITDA | 7.15 | Fwd EV/EBITDA | 3.48 |
| Forward P/S | 3.31 | Fwd Earnings Yield | 8.47% |
| FCF Yield | 13.47% | ||
| Market Cap | 1.45B | Enterprise Value | 1.17B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 425.13M | 358.71M | 310.46M | 331.34M | 391.87M |
| Net Income | 271.17M | 23.39M | 179.72M | 213.92M | 265.85M |
| EPS (Diluted) | 3.30 | 0.36 | 2.20 | 2.37 | 2.87 |
| Gross Profit | 307.52M | 322.11M | 267.82M | 317.55M | 391.87M |
| Operating Income | 163.75M | 166.87M | 113.89M | -36.95M | 375.10M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.64B | 1.30B | 1.24B | 1.23B | 926.40M |
| Total Liabilities | 462.32M | 609.90M | 568.55M | 665.71M | 400.46M |
| Shareholders' Equity | 1.17B | 691.16M | 674.96M | 565.79M | 414.74M |
| Total Debt | 269.02M | 451.10M | 449.08M | 544.07M | 394.76M |
| Cash & Equivalents | 550.94M | 304.96M | 193.51M | 291.05M | 201.53M |
| Current Assets | 727.52M | 554.31M | 344.22M | 443.51M | 313.67M |
| Current Liabilities | 49.70M | 236.08M | 38.13M | 134.97M | 5.81M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Capital Light Compounder
#52 of 220
Recent Activity
Exited
Contrarian Investing (David Dreman)
Mar 26, 2026
Entered
Capital Light Compounder
Mar 24, 2026
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026